ÂÜÀòÂÒÂ×

The Clinical Development Team at Cantargia is responsible for designing and overseeing clinical trials aimed at evaluating the safety and efficacy of the company's antibody-based treatment targeting IL1RAP in various cancer types. The team collaborates closely with regulatory bodies, manages project timelines, and ensures compliance with clinical standards, while integrating insights from preclinical research to drive advancements in therapeutic development.